← Back to Search

HPV Vaccine Optimization Strategies for Human Papillomavirus

N/A
Recruiting
Led By Noel T Brewer, PhD
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 13 months to 24 months
Awards & highlights

Study Summary

This trial studies how to increase HPV vaccine use in primary care clinics, with communication training and tools to optimize standing orders. #covid19

Who is the study for?
This trial is for primary care clinics that vaccinate children aged 9-12 against HPV but have vaccination rates below 72%. Clinics must have standing orders for the vaccine, which they either don't use routinely or are willing to adopt. Staff must complete a follow-up survey. Children and clinics not meeting these criteria are excluded.Check my eligibility
What is being tested?
The study tests whether communication training combined with optimized standing orders increases HPV vaccination rates in clinics. Some clinics will receive only training, while others will get both training and tools to improve their standing order usage.See study design
What are the potential side effects?
Since this trial focuses on staff training and procedural changes rather than medical interventions, there aren't direct side effects like those associated with drugs or vaccines.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 13 months to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from 13 months to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Estimated recommendation frequency, 11-12 year olds
Estimated recommendation frequency, 9-10 year olds
Estimated time spent on recommendations
+15 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: HPV vaccine communication training and standing orders optimizationExperimental Treatment1 Intervention
Staff in clinics randomized to this arm will receive the AAT and conduct a set of activities to optimize use of HPV vaccine standing orders.
Group II: HPV vaccine communication trainingExperimental Treatment1 Intervention
Staff in clinics randomized to this arm will receive an intervention called Announcement Approach Training (AAT). This training is designed to improve communication about HPV vaccination.

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor
348 Previous Clinical Trials
88,137 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,927,313 Total Patients Enrolled
Noel T Brewer, PhDPrincipal InvestigatorUniversity of North Carolina
8 Previous Clinical Trials
5,574 Total Patients Enrolled

Media Library

HPV vaccine communication training Clinical Trial Eligibility Overview. Trial Name: NCT05742386 — N/A
Human Papillomavirus Research Study Groups: HPV vaccine communication training, HPV vaccine communication training and standing orders optimization
Human Papillomavirus Clinical Trial 2023: HPV vaccine communication training Highlights & Side Effects. Trial Name: NCT05742386 — N/A
HPV vaccine communication training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05742386 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals who have not yet reached the age of seventy able to participate in this experiment?

"This trial has stipulated that it will only accept participants aged between 9 and 12, in accordance with the established criteria for enrollment."

Answered by AI

Are there still any vacancies available within the framework of this research endeavor?

"The clinical trial posted on February 22nd, 2023 is not presently recruiting patients. Despite this, the latest update was recorded on February 13th and there are 89 other studies that have openings for candidates now."

Answered by AI

Who is the target demographic for this research study?

"This trial is seeking 34 minors aged 9-12 with HPV, who attend clinics willing to employ standing orders prior to the start of the study and have vaccination rates below 72%. Vaccination data from children and survey responses from clinical staff will be collected. Both must meet follow-up criteria at 12 or 24 months in order for their records to be included."

Answered by AI
~18 spots leftby Jun 2025